ID Management A/S’s Amgen AMGN Stock Holding History

ID Management A/S’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,800	Closed	-$664K	–	299
2015 Q3	$664K	Buy	+4,800	New	+$757K	0.29%	61
2015 Q1	$767K	Buy	4,800 +2,100	+78%	+$331K	0.36%	61
2014 Q4	$430K	Buy	+2,700	New	+$421K	0.2%	82

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ID Management A/S's AMGN Position: Q4 2015 in Review

ID Management A/S sold out of Amgen (AMGN) in Q4 2015, closing a stake of 4,800 shares — an estimated $664K sold.

ID Management A/S first reported a position in AMGN in Q4 2014 and held it in 3 quarters. The position peaked at $767K in Q1 2015. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

ID Management A/S reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
ID Management A/S sold 4,800 Amgen shares in Q4 2015, an estimated $664K.
ID Management A/S first reported a position in Amgen in Q4 2014 and held it in 3 quarters.
ID Management A/S's Amgen position peaked at $767K in Q1 2015.
1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on ID Management A/S's 13F filing for Q4 2015, filed 13 Jan 2016.